Blu-945 (EGFR inhibitor)

ARV-471 (estrogen receptor PROTAC degrader)

ARV-110 (androgen receptor PROTAC degrader)

AG-270 (MAT2A inhibitor)

PF-07321332 (3CLPRO inhibitor)

EIDD-2801 (COVID-19)

RMC-6291 (KRAS^G12C(ON) inhibitor)

AB928

BMVC-8C3O

ACH-4471; Danicopan

NDI-091143

JND3229

VU6015929

VH-298

Adriforant tartrate hydrate

Adriforant tartrate hydrate, also known as ZPL-3893787 tartrate hydrate, PF-3893787 tartrate hydrate and ZPL-389 tartrate hydrate, is a novel histamine H4 receptor antagonist. Adriforant tartrate hydrate shows an excellent in vitro profile that warrants their further investigation in relevant models of human disease. Histamine H4 receptor (H4R) has become a promising target for immuno-inflammatory diseases, such as allergic rhinitis, asthma or dermal allergies.

Cat. No.: EX-A7359	Purity: >98%
	Chemical structure of Adriforant tartrate hydrate

For research only, Do not use for Human!